Literature DB >> 21856554

Heterogeneity of histological transformation events in Waldenström's macroglobulinemia (WM) and related disorders.

R G Owen1, A G Bynoe, A Varghese, R M de Tute, A C Rawstron.   

Abstract

Histological transformation, typically to diffuse large B-cell lymphoma (DLBCL) is reported to occur in 5%-10% of patients with WM and recent studies have highlighted a possible aetiological role for the nucleoside analogues. It is however becoming increasingly clear that histological transformation is a complex phenomenon and may include clonally unrelated disorders. In order to highlight this pathological heterogeneity we describe 5 patients with diverse histological progression events. These included EBV-associated events namely DLBCL, peripheral T-cell lymphoma and spontaneously resolving mucocutaneous ulcer. A further 2 patients demonstrated a localised plasma cell rich lesion simulating plasmacytoma and a de novo DLBCL arising in an unrelated B-cell clone. It is clear therefore that detailed pathological assessments are required in all suspected cases of transformation and that the pathological heterogeneity demonstrated by this study needs to be taken into account when potential aetiological factors are being assessed.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21856554     DOI: 10.3816/CLML.2011.n.042

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN: 2152-2669


  6 in total

1.  Rare transformation to double hit lymphoma in Waldenstrom's macroglobulinemia.

Authors:  Onyemaechi N Okolo; Ariel C Johnson; Seongseok Yun; Stacy J Arnold; Faiz Anwer
Journal:  Immunotherapy       Date:  2017-08-03       Impact factor: 4.196

2.  Welcome to the 9th Volume of Immunotherapy.

Authors:  Sonia Mannan
Journal:  Immunotherapy       Date:  2017-01       Impact factor: 4.196

3.  Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia.

Authors:  Jorge J Castillo; Ramon Garcia-Sanz; Evdoxia Hatjiharissi; Robert A Kyle; Xavier Leleu; Mary McMaster; Giampaolo Merlini; Monique C Minnema; Enrica Morra; Roger G Owen; Stephanie Poulain; Marvin J Stone; Constantine Tam; Marzia Varettoni; Meletios A Dimopoulos; Steven P Treon; Efstathios Kastritis
Journal:  Br J Haematol       Date:  2016-07-05       Impact factor: 6.998

4.  Histologic Transformation in an Untreated Waldenstrom's Macroglobulinemia After 14 Years: Case Report and Review of the Literature.

Authors:  Elizabeth B Elimimian; Nadeem Bilani; Maria J Diacovo; Skirmante Sirvaitis; Chieh Lin Fu
Journal:  J Hematol       Date:  2021-02-06

5.  Occurrence of MYD88L265P and CD79B mutations in diffuse large b cell lymphoma with bone marrow infiltration: A case report.

Authors:  Wen-Ye Huang; Zhi-Yun Weng
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

Review 6.  Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models.

Authors:  Siegfried Janz
Journal:  ISRN Hematol       Date:  2013-09-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.